Jeremy Royle

745 total citations
8 papers, 498 citations indexed

About

Jeremy Royle is a scholar working on Pharmacology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeremy Royle has authored 8 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeremy Royle's work include Drug-Induced Adverse Reactions (3 papers), Vasculitis and related conditions (2 papers) and Mast cells and histamine (1 paper). Jeremy Royle is often cited by papers focused on Drug-Induced Adverse Reactions (3 papers), Vasculitis and related conditions (2 papers) and Mast cells and histamine (1 paper). Jeremy Royle collaborates with scholars based in United Kingdom and Belgium. Jeremy Royle's co-authors include Paul Kay, Alistair B.A. Boxall, William H. Gaze, Lihong Zhang, Helen Brown, Elizabeth M. H. Wellington, Leo Calvo‐Bado, Peter M. Hawkey, Fiona Pearce and Peter Lanyon and has published in prestigious journals such as Annals of the Rheumatic Diseases, The ISME Journal and Lara D. Veeken.

In The Last Decade

Jeremy Royle

7 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Royle United Kingdom 5 303 172 104 66 48 8 498
Aolin Li China 12 285 0.9× 121 0.7× 294 2.8× 69 1.0× 23 0.5× 34 639
Xueli Tian China 15 188 0.6× 101 0.6× 121 1.2× 51 0.8× 12 0.3× 37 585
Jingyuan Zhu China 16 194 0.6× 95 0.6× 111 1.1× 54 0.8× 12 0.3× 31 631
Di Shen China 11 95 0.3× 24 0.1× 46 0.4× 15 0.2× 17 0.4× 30 345
Xiyuan Xu China 16 27 0.1× 54 0.3× 257 2.5× 127 1.9× 32 0.7× 33 582
Timothy J. Hamp United States 10 98 0.3× 12 0.1× 495 4.8× 129 2.0× 40 0.8× 11 844
Macario Martínez‐Castillo Mexico 9 84 0.3× 27 0.2× 187 1.8× 13 0.2× 9 0.2× 21 719
Wenjing Bi China 10 128 0.4× 53 0.3× 34 0.3× 26 0.4× 4 0.1× 29 341
Kôtarô Uchida Japan 12 167 0.6× 35 0.2× 61 0.6× 5 0.1× 18 0.4× 35 640

Countries citing papers authored by Jeremy Royle

Since Specialization
Citations

This map shows the geographic impact of Jeremy Royle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Royle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Royle more than expected).

Fields of papers citing papers by Jeremy Royle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Royle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Royle. The network helps show where Jeremy Royle may publish in the future.

Co-authorship network of co-authors of Jeremy Royle

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Royle. A scholar is included among the top collaborators of Jeremy Royle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Royle. Jeremy Royle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Saldanha, Gerald, et al.. (2021). Toxic epidermal necrolysis‐like lupus. Clinical and Experimental Dermatology. 46(7). 1299–1303. 6 indexed citations
3.
Royle, Jeremy, et al.. (2019). 136 Sulfasalazine induced DRESS syndrome: a rare side effect of a common medication. Lara D. Veeken. 58(Supplement_3). 2 indexed citations
4.
Royle, Jeremy, Peter Lanyon, Matthew J. Grainge, Abhishek Abhishek, & Fiona Pearce. (2018). The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clinical Rheumatology. 37(8). 2103–2111. 58 indexed citations
5.
Royle, Jeremy, et al.. (2017). Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis. Clinical Rheumatology. 37(4). 1085–1090. 17 indexed citations
6.
Royle, Jeremy, et al.. (2013). AB0332 Rituximab & immunoglobulin level monitoring in rheumatoid arthritis – a clinical audit. Annals of the Rheumatic Diseases. 72. A888–A889. 1 indexed citations
7.
Gaze, William H., Lihong Zhang, Peter M. Hawkey, et al.. (2011). Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-associated genes in the environment. The ISME Journal. 5(8). 1253–1261. 346 indexed citations
8.
Blombery, Peter, David J. Effeney, Juliette Harris, et al.. (1989). Prevention of atherosclerotic complications: Controlled trial of ketanserin. 298(6671). 424–430. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026